MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the Goldman Sachs 2023 US Financial Services Conference
NEW YORK–(BUSINESS WIRE)–MetLife, Inc. (NYSE: MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive... Read more.
Elastic to Announce Second Quarter Fiscal 2024 Earnings Results on Thursday, November 30, 2023
SAN FRANCISCO–(BUSINESS WIRE)–Elastic (NYSE: ESTC) (“Elastic”), the company behind Elasticsearch®, announced that it will release its financial... Read more.
ChargePoint Announces Executive Leadership Changes
CAMPBELL, Calif.–(BUSINESS WIRE)–ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles, has appointed Rick... Read more.
Alpha and Omega Semiconductor to Participate in 12th Annual CEO Investor Summit 2023
SUNNYVALE, Calif.–(BUSINESS WIRE)–Alpha and Omega Semiconductor Limited (“AOS”) (Nasdaq: AOSL) today announced that company management will... Read more.
Alpha and Omega Semiconductor to Participate in 12th Annual CEO Investor Summit 2023
SUNNYVALE, Calif.–(BUSINESS WIRE)–Alpha and Omega Semiconductor Limited (“AOS”) (Nasdaq: AOSL) today announced that company management will... Read more.
NetApp Appoints Anders Gustafsson to the Board of Directors
SAN JOSE, Calif.–(BUSINESS WIRE)–NetApp (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced that Anders Gustafsson, executive... Read more.
NetApp Appoints Anders Gustafsson to the Board of Directors
SAN JOSE, Calif.–(BUSINESS WIRE)–NetApp (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced that Anders Gustafsson, executive... Read more.
Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
Results demonstrate KarXT was not associated with clinically meaningful increases in blood pressure in adults with schizophrenia KarXT demonstrated a mean change... Read more.
Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
Results demonstrate KarXT was not associated with clinically meaningful increases in blood pressure in adults with schizophrenia KarXT demonstrated a mean change... Read more.
The Results are In: Digital Payments are a Prescription for Patient Satisfaction
71% of patients said that receiving fast and secure digital refunds would improve their overall satisfaction. CHICAGO & PHILADELPHIA–(BUSINESS WIRE)–Onbe,... Read more.